Dutch Investors Back Preventive Health Programme with €1.5 Million to Bridge the Life Expectancy Gap

Dutch Investors Back Preventive Health Programme with €1.5 Million to Bridge the Life Expectancy Gap

2026-03-31 biotech

Amsterdam, Tuesday 31 March 2026
To combat a 21-year disparity in healthy life expectancy, Invest-NL and partners have injected €1.5 million into GelijkGezond, an innovative results-based preventive healthcare programme for low-income citizens.

Re-engineering Healthcare Financing

The financial architecture underpinning the GelijkGezond initiative represents a significant departure from traditional healthcare funding models [GPT]. Invest-NL, the Dutch state-backed impact investor, has facilitated a results-based financing structure, committing to a €1.5 million loan as of late February 2026 [2]. This capital injection is part of a broader collaborative effort involving major institutional investors, including the Noaber Foundation, Rabobank, and the Pensioenfonds Zorg en Welzijn (PFZW), with the latter’s investment managed by PGGM [2][4][6]. Under this innovative outcome-based model, private investors pre-finance the preventive care interventions [3][7]. Municipalities and health insurers are only required to reimburse these upfront costs once pre-agreed, measurable societal impacts have been successfully achieved [3][6][7].

The ‘Doorbijters’ Approach to Complex Social Challenges

At the operational core of GelijkGezond is the deployment of dedicated professionals known as ‘doorbijters’ or ‘persistents’ [3][8]. These specialists are tasked with providing integrated support to citizens facing a complex accumulation of challenges that span across health, housing, debt management, and employment [2][3][6]. Because these interconnected issues are often too multifaceted for standard, siloed regulatory systems to handle effectively, vulnerable individuals frequently fall through the cracks [5][8]. The ‘doorbijters’ operate outside traditional bureaucratic boundaries, collaborating directly with general practitioners and social domain workers to tackle the root causes of distress comprehensively rather than addressing symptoms in isolation [5][6][8].

Institutional Backing and Future Scalability

Invest-NL’s involvement marks a strategic transition from the conceptual development phase of the financing model into active execution [2]. The organisation’s business development manager, Louise Blankensteijn, alongside colleagues Ineke Cazander and Vera Ederveen, played a pivotal role in structuring this financeable proposition for founders Marcel Geurts and Joris van Eijck [3][7]. Looking ahead, Invest-NL plans to further refine the conditions and propositions necessary to make results-based financing more broadly accessible for other social transitions [2][3]. Should the current interventions prove successful, GelijkGezond intends to expand its operations to additional municipalities across the Netherlands, establishing a scalable blueprint for preventive healthcare funding [8].

Judicial System Reforms to Address Capacity Shortfalls

In a separate but notable regulatory development affecting the Dutch administrative and legal landscape, the Ministry of Justice and Security announced a structural reform today, 31 March 2026, to address ongoing capacity constraints within the judiciary [1]. State Secretary for Justice and Security, Claudia van Bruggen, informed the House of Representatives that a temporary measure allowing judges to continue working as substitutes past the statutory retirement age of 70 will be made permanent [1]. Under the forthcoming legislative amendment, experienced judges will be permitted to serve as substitutes for an additional three years, extending their potential service age to 73 years [1].

Sources & Ecosystem Partners

  1. www.rijksoverheid.nl
  2. www.invest-nl.nl
  3. www.invest-nl.nl
  4. nl.linkedin.com
  5. www.instagram.com
  6. nl.linkedin.com
  7. nl.linkedin.com
  8. www.skipr.nl

Regulatory policy Healthcare investment